• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

F.D.A. Approves a New Antipsychotic Drug

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.

Ellen Barry
Author: Ellen Barry

Written by

Ellen Barry

in

Clinical Trials, Dopamine, Drugs (Pharmaceuticals), Food and Drug Administration, Karuna Therapeutics Inc, Psychiatry and Psychiatrists, Psychology and Psychologists, Regulation and Deregulation of Industry, Research, Schizophrenia, Therapy and Rehabilitation
←Museum at FIT Tells the Story of the African Diaspora Through Its Fashions
Inside the U.N. Dinner Party at Eleven Madison Park→

More posts

  • Why This Josie Maran Body Butter is My Holy Grail 

  • Aluminium, Helium and Sulfur: The Iran War Is Affecting More Than Oil

  • Senate Moves Toward Passing Sweeping Housing Bill, but Challenges Lie Ahead

  • Girl, Log Off: A Guide To Recharging On National Day Of Rest For Black Women

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube